Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals Inc is a specialty pharmaceutical company engaged in developing, manufacturing, marketing and selling generic and proprietary injectable & inhalation products. Its products are used in hospitals or urgent care clinical settings.
IPO Date: June 25, 2014
Sector: Healthcare
Industry: Drug Manufacturers
Market Cap: $1.22B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.40 | 1.67%
Avg Daily Range (30 D): $0.38 | 1.52%
Avg Daily Range (90 D): $0.47 | 1.77%
Institutional Daily Volume
Avg Daily Volume: .25M
Avg Daily Volume (30 D): .4M
Avg Daily Volume (90 D): .47M
Trade Size
Avg Trade Size (Sh.): 67
Avg Trade Size (Sh.) (30 D): 43
Avg Trade Size (Sh.) (90 D): 45
Institutional Trades
Total Inst.Trades: 2,281
Avg Inst. Trade: $1.79M
Avg Inst. Trade (30 D): $1.85M
Avg Inst. Trade (90 D): $1.96M
Avg Inst. Trade Volume: .06M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.09M
Avg Closing Trade (30 D): $2.1M
Avg Closing Trade (90 D): $2.45M
Avg Closing Volume: 68.37K
   
News
Jun 5, 2025 @ 5:00 PM
Global Antidote Market to Cross the USD 4 Billion ...
Source: Delveinsight
Sep 6, 2024 @ 5:46 PM
JP Morgan Shows Most Interest In Teva, Organon As ...
Source: Vandana Singh
Jul 23, 2024 @ 5:01 PM
HCA Healthcare (HCA) Beats on Q2 Earnings, Ups 202...
Source: N/A
May 30, 2024 @ 6:06 AM
Amphastar Pharmaceuticals: Buy When Fear Is Overbl...
Source: James Long
May 15, 2024 @ 12:36 PM
Implied Volatility Surging for Amphastar (AMPH) St...
Source: Zacks Equity Research
Financials
  TTM Q1 2025 Q3 2024
Basic EPS $.53 $.83
Diluted EPS $.51 $.78
Revenue $ $ 170.53M $ 191.21M
Gross Profit $ $ 85.25M $ 101.94M
Net Income / Loss $ $ 25.29M $ 40.43M
Operating Income / Loss $ $ 37.29M $ 57.05M
Cost of Revenue $ $ 85.28M $ 89.27M
Net Cash Flow $ $ 31.17M $ 2.5M
PE Ratio